Status:
COMPLETED
Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)
Lead Sponsor:
Ohio State University
Conditions:
Sepsis, Severe Sepsis and Septic Shock
Eligibility:
All Genders
18-90 years
Brief Summary
The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitione...
Eligibility Criteria
Inclusion
- Adult (≥18 to 90 years)
- Patients presenting to the Emergency Department
- CBC (Complete Blood Count) with differential testing performed and CPD data retrieved
Exclusion
- Previously enrolled in this study
Key Trial Info
Start Date :
July 14 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2015
Estimated Enrollment :
1320 Patients enrolled
Trial Details
Trial ID
NCT02232750
Start Date
July 14 2014
End Date
August 15 2015
Last Update
November 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wexner Medical Center at The Ohio State University
Columbus, Ohio, United States, 43210